SNMMI expressed support for the US Department of Energy's postponement of a ban on export licenses for highly enriched uranium used in producing medical radioisotopes amid an inadequate supply of molybdenum-99. "The two-year delay is a very positive development for patients whose care is facilitated by this important nuclear medicine isotope," SNMMI said.
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.